NOsocomial Dissemination Risk of SARS-Cov2
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,523
- 试验地点
- 1
- 主要终点
- Understanding the dissemination of SARS Cov2 in hospital
研究概览
简要总结
To date, in France, in the context of the SARS Cov2 pandemic,both the number of affected subjects and the number of severe forms requiring hospital care are increasing.
Several nosocomial transmission clusters have already been identified in hospitals (both pediatric and adult) but there is still limited data on the nosocomial spread of SARS-Cov2.
This nosocomial transmission affects both patients and caregivers. It is important to understand the spread of the virus within the hospital. This will help to optimize procedures to prevent transmission to caregivers and hospitalizedpatients not infected with SARS Cov2, and more generally this will contribute to control the spread of SARS Cov2 in the community
详细描述
It is an observational study without any risk. Every participating service will be investigated for 2 consecutive days .
- At each staff rotation, an individualsensorwill be provided toall thestaff(caregivers, administrative, students etc...) to be worn duringtheirworking hours. Also a sensor will be placed at each patient's bedside.
- In addition, epidemiological data relating to socio-demographic characteristics, profession, protective measures will be collectedfrom hospitalstaff. Also, some data from the 'entrepot des données de santé" regarding individual carepathways in the hospitalwill be extracted.
- A map of the unit, specifying the location of each patient will be made.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Understanding the dissemination of SARS Cov2 in hospital
时间窗: 2 days
In each unit, during 2 days, Patients and all staff (caregivers, administrative, students...) will carry an individualsensorwhich will regularly measure the proximity between 2 sensors
次要结局
- Optimizing hospital strategies to prevent transmission to caregivers and not infected hospitalized patients with SARSCov2(8 weeks)